What does CD Farma do?

CD Farma is filed with the CBE under the catch-all “Overige financiële dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 21 January 2016, 1 establishment.

What is the address of CD Farma?

The registered office of CD Farma is located at Liersebaan 1, 2240 Zandhoven.

Is CD Farma still active?

Yes. According to the CBE (16 September 2026) CD Farma is active, legal situation “Normale toestand”, started on 21 January 2016.

Is CD Farma registered on Peppol?

Yes, CD Farma is registered on the Peppol network with ID 0208:0646871620.

What is the enterprise number of CD Farma?

The enterprise number of CD Farma is BE0646871620.

When was CD Farma founded?

CD Farma was founded on 21 January 2016.

Who are the directors of CD Farma?

According to the 2025 annual accounts, the directors of CD Farma are: Charlotte Denys.

Is CD Farma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CD Farma make in 2025?

CD Farma posted a profit after taxes of € 100,971 in financial year 2025.

What is the revenue of CD Farma?

As a small company, CD Farma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 152,975.

CD Farma (Private Limited) - Zandhoven - BE0646871620

Dossier CD Farma, printed on 16 September 2026 from databakkes.be/en/0646871620/cd-farma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

CD Farma from Zandhoven, company number BE0646871620, closed financial year 2025 with a result of € 100,971 after tax. For that financial year CD Farma recorded a gross margin of € 152,975 and equity of € 706,783. Compared with financial year 2024, the result moved from € 101,626 to € 100,971. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What it is worth Growing

€ 706,783

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 100,971

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 37,440

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 688,183.

People and assets in 2025

Vehicles and equipment

€ 43,637

▲ 122% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 438,818

▼ 15% vs 2024

€ 79,627 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 33,750

▲ € 33,111 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,868

▼ 12% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 111,020 Gross margin 2022: € 111,020 First fiscal year in the series	€ 145,866 Gross margin 2023: € 145,866 ▲ 31% vs 2022 (€ 111,020) Favourable step	€ 153,102 Gross margin 2024: € 153,102 ▲ 5% vs 2023 (€ 145,866) Favourable step	€ 152,975 Gross margin 2025: € 152,975 Unchanged (€ 153,102) Unfavourable step
Profit after taxes	€ 69,606 Profit after taxes 2022: € 69,606 First fiscal year in the series	€ 97,730 Profit after taxes 2023: € 97,730 ▲ 40% vs 2022 (€ 69,606) Favourable step	€ 101,626 Profit after taxes 2024: € 101,626 ▲ 4% vs 2023 (€ 97,730) Favourable step	€ 100,971 Profit after taxes 2025: € 100,971 ▼ 1% vs 2024 (€ 101,626) Unfavourable step	▼ 1%
Equity	€ 431,455 Equity 2022: € 431,455 First fiscal year in the series	€ 529,185 Equity 2023: € 529,185 ▲ 23% vs 2022 (€ 431,455) Favourable step	€ 605,811 Equity 2024: € 605,811 ▲ 14% vs 2023 (€ 529,185) Favourable step	€ 706,783 Equity 2025: € 706,783 ▲ 17% vs 2024 (€ 605,811) Favourable step	▲ 17%
Total debts	€ 734,422 Total debts 2022: € 734,422 First fiscal year in the series	€ 645,166 Total debts 2023: € 645,166 ▼ 12% vs 2022 (€ 734,422) Favourable step	€ 597,544 Total debts 2024: € 597,544 ▼ 7% vs 2023 (€ 645,166) Favourable step	€ 514,416 Total debts 2025: € 514,416 ▼ 14% vs 2024 (€ 597,544) Favourable step	▼ 14%
Cash	€ 27,987 Cash 2022: € 27,987 First fiscal year in the series	€ 36,102 Cash 2023: € 36,102 ▲ 29% vs 2022 (€ 27,987) Favourable step	€ 45,350 Cash 2024: € 45,350 ▲ 26% vs 2023 (€ 36,102) Favourable step	€ 37,440 Cash 2025: € 37,440 ▼ 17% vs 2024 (€ 45,350) Unfavourable step	▼ 17%
Retained profit	€ 412,855 Retained profit 2022: € 412,855 First fiscal year in the series	€ 510,585 Retained profit 2023: € 510,585 ▲ 24% vs 2022 (€ 412,855) Favourable step	€ 587,211 Retained profit 2024: € 587,211 ▲ 15% vs 2023 (€ 510,585) Favourable step	€ 688,183 Retained profit 2025: € 688,183 ▲ 17% vs 2024 (€ 587,211) Favourable step	▲ 17%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 25,000 Dividend 2024: € 25,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 25,000) Unchanged	▼ 100%
Bank debt	€ 670,659 Bank debt 2022: € 670,659 First fiscal year in the series	€ 594,535 Bank debt 2023: € 594,535 ▼ 11% vs 2022 (€ 670,659) Favourable step	€ 517,260 Bank debt 2024: € 517,260 ▼ 13% vs 2023 (€ 594,535) Favourable step	€ 438,818 Bank debt 2025: € 438,818 ▼ 15% vs 2024 (€ 517,260) Favourable step	▼ 15%
Balance sheet total	€ 1,165,877 Balance sheet total 2022: € 1,165,877 First fiscal year in the series	€ 1,174,351 Balance sheet total 2023: € 1,174,351 ▲ 1% vs 2022 (€ 1,165,877) Unchanged	€ 1,203,355 Balance sheet total 2024: € 1,203,355 ▲ 2% vs 2023 (€ 1,174,351) Unchanged	€ 1,221,199 Balance sheet total 2025: € 1,221,199 ▲ 1% vs 2024 (€ 1,203,355) Unchanged	▲ 1%

Key figures of CD Farma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CD Farma?

What happened at CD Farma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 26, 2026 New annual accounts for financial year 2025: profit of € 100,971 (▼ 1% vs 2024). Source: NBB ↗
Jan 21, 2016 New establishment in Zandhoven. KBO
Jan 21, 2016 Start of the company according to the CBE. KBO
2016 Charlotte Denys became a director. NBB

In short

From € 69,606 profit in 2022 to € 100,971 profit in 2025.

Paid € 127,964 in corporate taxes since 2022.

Best year ever: 2024, with € 101,626 profit.

Paid out € 25,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at CD Farma? We notify you, reason included.

Follow CD Farma

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charlotte Denys

CD Farma

Apotheek Denys Zandhoven BV 50%

Behind CD Farma is Charlotte Denys. It owns 50% of Apotheek Denys Zandhoven BV itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Charlotte Denys

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Liersebaan 1

2240 Zandhoven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

APOTHEEK DENYS ZANDHOVEN same network

€ 397,159 gross margin · 2025

Hair By Marcia

ID Farma

€ 153,078 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0646.871.620
VAT number: BE 0646.871.620
Registered office: Liersebaan 1, 2240 Zandhoven
Names & denominations: CD Farma
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 January 2016
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Overige financiële dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗